1. Home
  2. RPTX vs MSD Comparison

RPTX vs MSD Comparison

Compare RPTX & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • MSD
  • Stock Information
  • Founded
  • RPTX 2016
  • MSD 1993
  • Country
  • RPTX Canada
  • MSD United States
  • Employees
  • RPTX N/A
  • MSD N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • MSD Trusts Except Educational Religious and Charitable
  • Sector
  • RPTX Health Care
  • MSD Finance
  • Exchange
  • RPTX Nasdaq
  • MSD Nasdaq
  • Market Cap
  • RPTX 141.1M
  • MSD 161.1M
  • IPO Year
  • RPTX 2020
  • MSD N/A
  • Fundamental
  • Price
  • RPTX $1.32
  • MSD $7.36
  • Analyst Decision
  • RPTX Strong Buy
  • MSD
  • Analyst Count
  • RPTX 3
  • MSD 0
  • Target Price
  • RPTX $7.00
  • MSD N/A
  • AVG Volume (30 Days)
  • RPTX 709.5K
  • MSD 70.2K
  • Earning Date
  • RPTX 11-07-2024
  • MSD 01-01-0001
  • Dividend Yield
  • RPTX N/A
  • MSD 11.26%
  • EPS Growth
  • RPTX N/A
  • MSD N/A
  • EPS
  • RPTX N/A
  • MSD N/A
  • Revenue
  • RPTX $66,524,000.00
  • MSD N/A
  • Revenue This Year
  • RPTX $13.22
  • MSD N/A
  • Revenue Next Year
  • RPTX N/A
  • MSD N/A
  • P/E Ratio
  • RPTX N/A
  • MSD N/A
  • Revenue Growth
  • RPTX 18.19
  • MSD N/A
  • 52 Week Low
  • RPTX $1.23
  • MSD $6.11
  • 52 Week High
  • RPTX $8.49
  • MSD $7.46
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 30.27
  • MSD 28.12
  • Support Level
  • RPTX $1.23
  • MSD $7.56
  • Resistance Level
  • RPTX $4.07
  • MSD $8.08
  • Average True Range (ATR)
  • RPTX 0.34
  • MSD 0.13
  • MACD
  • RPTX -0.20
  • MSD -0.06
  • Stochastic Oscillator
  • RPTX 3.34
  • MSD 3.95

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: